Akimichi Asano

605 citations
18 papers · 380 indexed · h-index 9

Akimichi Asano

18 papers receiving 367 citations

Peers

Akimichi Asano
Comparison fields: 5 of 68
  • Endocrinology, Diabetes and Metabolism 131
  • Physiology 127
  • Cardiology and Cardiovascular Medicine 105
  • Epidemiology 136
  • Endocrine and Autonomic Systems 17
Replace Silvia Vichi with:
Silvia Vichi Italy
Kang Seo Park South Korea
Adelina Tsakova Bulgaria
Alecia Blaszczak United States
Maria Rosaria Manigrasso Italy
Luz Elizabeth Guillén-Pineda Mexico
Won Seon Jeon South Korea
Sulin Zheng China
Frida Peiffer Belgium
Alberto Premoli Italy
Akimichi Asano relative to Silvia Vichi Italy Silvia Vichi's profile →
Citations per field
00.5×1.5×
Silvia Vichi · 1×
Citations per year

Countries citing papers authored by Akimichi Asano

Since Specialization
Citations

This map shows the geographic impact of Akimichi Asano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akimichi Asano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akimichi Asano more than expected).

Fields of papers citing papers by Akimichi Asano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akimichi Asano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akimichi Asano. The network helps show where Akimichi Asano may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Akimichi Asano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Akimichi Asano Line = papers co-authored together Akimichi Asano links everyone, so they are left out of the graph.

All Works

18 of 18 papers shown
#Work
1 20181
2 20138
3 20081
4 200744
5 20073
6 200719
7 2007133
8 200623
9 200634
10 20067
11 20064
12 200628
13 20052
14 20058
15 200538
16 20047
17 20034
18 200216

About Akimichi Asano

Akimichi Asano is a scholar working on Endocrinology, Diabetes and Metabolism, Biochemistry and Epidemiology, having authored 18 papers that have together received 380 indexed citations. Recurring topics across this work include Adipokines, Inflammation, and Metabolic Diseases (9 papers), Adipose Tissue and Metabolism (5 papers), Diabetes Management and Research (3 papers), Cardiovascular Disease and Adiposity (2 papers), Nuclear Structure and Function (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Estrogen and related hormone effects (2 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (131 citations), Physiology (127 citations) and Cardiology and Cardiovascular Medicine (105 citations). Akimichi Asano has collaborated with scholars based in Japan. Frequent co-authors include Hiroshi Mabuchi, Junji Kobayashi, Atsushi Nohara, Kunimasa Yagi, Masakazu Yamagishi, Masa‐aki Kawashiri, Yuko Murase, Akihiro Inazu, Susumu Miyamoto and Rie Oka. Their work appears in journals such as European Journal of Pharmacology, Clinica Chimica Acta and Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026